Serum Institute to test if TB vaccine VPM1002 is effective against Covid-19

Serum Institute of India, the world ’s largest vaccine manufacturer, will soon start clinical trials in the country to test if tuberculosis vaccine VPM1002 is effective as a preventive and immunity booster vaccine against Covid-19.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news

Related Links:

Here’s betting you wouldn’t want anyone blowing smallpox scabs up your nose. But you might feel differently if you lived in 15th century China. Long ago, the Chinese recognized that people who had contracted smallpox once were immune to reinfection. They came up with the idea of preserving scabs from individuals who had suffered mild cases, drying them out, crushing them to a powder and blowing them up the nostril. For boys it was the right nostril, for girls it was the left because, well, 15th century. That is how the story of vaccines usually begins, though that version is decidedly incomplete. For one thing,...
Source: TIME: Science - Category: Science Authors: Tags: Uncategorized COVID-19 Explainer health Source Type: news
[IPS] This week, the Bill and Melinda Gates Foundation announced it will donate A$10 million to help fund an Australian trial testing whether a very old vaccine, BCG, can be used against a new threat, COVID-19. So what is the BCG vaccine and what might its place be in the fight against coronavirus?
Source: AllAfrica News: Tuberculosis - Category: Infectious Diseases Source Type: news
This article is republished from The Conversation under a Creative Commons license. Read the original article. The post Could BCG, a 100-year-old Vaccine for Tuberculosis, Protect Against Coronavirus? appeared first on Inter Press Service.
Source: IPS Inter Press Service - Health - Category: International Medicine & Public Health Authors: Tags: Global Headlines Health Source Type: news
Trained immunity is a type of non-specific memory-like immune response induced by some pathogens and vaccines, such as BCG, which can confer antigen-independent protection against a wide variety of pathogens. The BCG vaccine has been extensively used to protect against tuberculosis for almost a 100 years. Interestingly, this vaccine reduces children's mortality caused by infections unrelated to Mycobacterium tuberculosis infection, a phenomenon thought to be due to the induction of trained immunity. The SARS-CoV-2 pandemic has infected, as of April 22, 2020, 2,623,231 people globally, causing a major public health problem ...
Source: Frontiers in Immunology - Category: Allergy & Immunology Source Type: research
Sarah Boseley talks toProf Helen McShane about why there has been interest in the tuberculosis vaccine and whether it could play a role in protecting us against Covid-19Continue reading...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Science Biology Tuberculosis Microbiology Vaccines and immunisation Coronavirus outbreak Infectious diseases Health Medical research Source Type: news
Sarah Boseley talks toProf Helen McShane about why there has been interest in the tuberculosis vaccine and whether it could play a role in protecting us against Covid-19Continue reading...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Science Biology Tuberculosis Microbiology Vaccines and immunisation Coronavirus outbreak Infectious diseases Health Medical research Source Type: news
The map from the medical journal Plos Medicine displays BCG vaccination policy by country. Bacillus Calmette-Guérin vaccine is a vaccine primarily used against tuberculosis. Yellow: The country now has a universal BCG vaccination program. Blue: The country used to recommend BCG vaccination for everyone, but now does not. Red: The country never had a universal vaccination program.By Darini Rajasingham-SenanayakeCOLOMBO, Sri Lanka, Apr 20 2020 (IPS) Numerous studies in many parts of the world have linked the BCG (Bacillus Calmette-Guerin) vaccination, widely used in the developing world with fewer Coronavirus cases. T...
Source: IPS Inter Press Service - Health - Category: International Medicine & Public Health Authors: Tags: Development & Aid Economy & Trade Featured Global Headlines Health TerraViva United Nations Source Type: news
[Africa CDC] The Africa Centres for Disease Control and Prevention (Africa CDC) strongly condemns the very disgusting comments made by Professors Jean-Paul Mira and Camille Locht on French Television on using Africans for testing a tuberculosis vaccine in clinical trials to see if it is protective against COVID-19. These racist and condescending comments must be condemned by all decent human beings. Indeed, COVID-19 is a global humanitarian crisis that requires global actions and global solidarity.
Source: AllAfrica News: Tuberculosis - Category: Infectious Diseases Source Type: news
Researchers in at least four countries are testing whether the century-old vaccine for tuberculosis can lessen the severity of some COVID-19 cases.
Source: Health News: CBSNews.com - Category: Consumer Health News Source Type: news
A century-old vaccine used to treat tuberculosis, known as the BCG vaccine, is showing promise in treating coronavirus symptoms. In CBS News' latest installment of "Racing to a Cure," researchers say it might also lessen the severity of coronavirus by boosting the body's ability to fight off the infection before it gets worse. Debora Patta reports.
Source: Health News: CBSNews.com - Category: Consumer Health News Source Type: news
More News: Biotechnology | Clinical Trials | COVID-19 | India Health | Pharmaceuticals | Tuberculosis | Tuberculosis (BCG) Vaccine | Vaccines